Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Neuromodulation Market by the end of 2030?

The neuromodulation market has experienced significant expansion in recent years. This market is projected to grow from $7.62 billion in 2025 to $8.45 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. In the past, this growth was primarily driven by the increasing prevalence of chronic pain conditions, a rising incidence of neurological disorders, greater acceptance of minimally invasive therapies, the expansion of specialized pain management centers, and the availability of advanced implantable devices.

The neuromodulation market is projected to experience substantial expansion over the coming years, reaching $12.88 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.1%. This anticipated growth is primarily fueled by several factors, including the increasing integration of AI-assisted neuromodulation systems, a surging demand for home-based neuromodulation treatments, a broader range of applications for psychiatric and neurological disorders, an intensified focus on customized stimulation protocols for patients, and ongoing innovations in biomaterials and device miniaturization. Key developments expected during this period encompass a greater acceptance of implantable neuromodulation devices, an increasing preference for non-invasive neuromodulation therapies, the expanding incorporation of intelligent and programmable stimulators, the broadening scope of neuromodulation applications beyond pain management, and a heightened emphasis on individualized neurotherapy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What Drivers Are Shaping Future Opportunities In The Neuromodulation Market?

The neuromodulation market is anticipated to expand due to increasing healthcare expenditures. Healthcare expenditure refers to the comprehensive financial outlay on health care and associated endeavors, covering health service delivery, both private and public health insurance, health research, and public health programs. Growing expenditures contribute to the development and adoption of new therapies and diagnostic methods for neurological disorders. Additionally, increased funding allows for more research into new neuromodulation technologies, improving their efficacy, safety, and targeting capabilities. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, rising healthcare expenditure is driving the growth of the neuromodulation market.

Which Segment Groups Are Influencing The Neuromodulation Market?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Which Trends Are Expected To Influence The Neuromodulation Market In The Upcoming Years?

Major companies active in the neuromodulation market are concentrating on developing next-generation devices, such as advanced implantable pulse generators (IPGs), to enhance therapeutic precision, improve patient comfort, and maintain their competitive advantage. An IPG is a compact, battery-powered device surgically placed under the skin, typically in the chest or abdomen, which delivers targeted electrical stimulation for managing neurological disorders. These innovations aim to provide greater personalization, improved battery endurance, and simplified implantation procedures. For instance, in July 2023, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, secured FDA approval for its Vercise Neural Navigator 5 software, incorporating STIMVIEW XT technology, designed for use with the fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. This platform includes both rechargeable and non-rechargeable IPGs and supports five MR-Conditional implantable pulse generators (IPGs), offering the widest range of therapy options to customize DBS therapy for individuals with Parkinson’s disease or essential tremor.

Who Are The Prominent Global Companies Shaping The Neuromodulation Market Landscape?

Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Which Region Is Projected To Lead The Neuromodulation Market During The Forecast Period?

North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Neuromodulation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

Browse Through More Reports Similar to the Global Neuromodulation Market 2026, By The Business Research Company

Nephrologists Market Global Report 2020 2030 Covid 19 Implications And Growth 2026

https://www.thebusinessresearchcompany.com/report/nephrologists-market-global-report-2020-2030-covid-19-implications-and-growth

Neurology Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Brain Monitoring Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company